![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Roche’s COVID-19 Test Gets FDA Emergency Clearance
Roche’s COVID-19 Test Gets FDA Emergency Clearance
![roche.gif](https://www.fdanews.com/ext/resources/test/Device_Images/roche.gif?t=1600727553&width=430)
The FDA has granted Roche Emergency Use Authorization for its Elecsys Anti-SARS-CoV-2 S antibody test.
The lab-based blood test, which received CE mark certification in September, is used to gauge the level of antibodies in patients exposed to the coronavirus to measure their immune response, providing a numerical result. The test runs on the company’s cobase analyzers.
The diagnostic can also be used to help with the allocation of plasma donations from recovered COVID-19 patients to infected patients by identifying donors with antibodies to the virus, the company said.
Upcoming Events
-
21Oct